Provista Diagnostics

About:

Provista Diagnostics develops and commercializes blood-based diagnostic tests for the detection of oncology-related diseases.

Website: http://www.provistadx.com

Twitter/X: provistadx

Description:

Provista Diagnostics is a Delaware company, develops and commercializes breakthrough, easy-to-administer blood-based diagnostic tests for early oncology-related disease state recognition and detection purposes. The Company's focus is on oncology-related diagnostics where a significantly high, unmet clinical need for such testing products exists. Near-term development and commercialization efforts focus on women's cancers such as breast and ovarian cancer. Provista Diagnostic’s technologies are developed at our CLIA accredited, GLP compliant, 13,610 sq/ft laboratory facility based in Scottsdale, Arizona. Recently, Provista has formed corporate headquarters in New York to take advantage of the sales, marketing, regulatory and financial expertise in the northeast US.

Total Funding Amount:

$34.5M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

New York, New York, United States

Founded Date:

2007-01-01

Contact Email:

holmesd(AT)provistadx.com

Founders:

Number of Employees:

11-50

Last Funding Date:

2016-03-19

IPO Status:

Private

Industries:

© 2025 bioDAO.ai